Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Study of Efficacy and Safety of Different Strengths of Spinosad Topical Creme Rinse (0%, 0.5% or 1.0%) in Subjects 2 Years of Age or Older With Pediculosis Capitis - A Dose Ranging Study

NCT00311779 is registered in ClinicalTrials.gov with ParaPRO LLC as lead sponsor.

NCT NCT00311779
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00311779 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Study of Efficacy and Safety of Different Strengths of Spinosad Topical Creme Rinse (0%, 0.5% or 1.0%) in Subjects 2 Years of Age or Older With Pediculosis Capitis - A Dose Ranging Study
Lead sponsor
ParaPRO LLC
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2006
Completion date
July 31, 2006
Enrollment
120
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

pediculosis capitis (head lice)